Interns and residents at Korea’s "Big Five" hospitals have decided to submit their resignations by Monday and stop working from Tuesday.Park Dan, head of the Korean Intern and Resident Association (KIRA), said the association came to this conclusion after discussions with representatives of the trai
Lunit announced a record-breaking revenue of 25 billion won ($21 million) for 2023, marking an 80.9 percent increase from 13.8 billion won a year earlier, thanks to a continued expansion of overseas sales of medical AI solutions. Last year, the Kosdaq-listed company posted an operating loss of appro
In a controversial move, the Korean government announced a plan to increase the admission quota for medical schools by 2,000 students on Feb. 6, sparking fierce opposition from the medical community, including the Korean Medical Association (KMA) and other healthcare organizations.The medical commun
Gradiant Bioconvergence said Thursday that it has entered into a research collaboration agreement with U.S. messenger ribonucleic acid (mRNA) therapeutics developer Strand Therapeutics to develop next-generation mRNA therapeutics.Under the agreement, the companies will collaborate on developing a fo
JW Pharmaceutical said Wednesday that the U.S. Drug Safety Monitoring Board (DSMB) has positively reviewed top-line results from its multinational phase 3 clinical trial of Epaminurad (codenamed URC102) for gout and recommended continuing the trial.On Jan. 31, the DSMB, comprised of U.S. rheumatolog
LifeSemantics said Thursday that it has completed the confirmatory clinical trial of its skin cancer image detection and diagnostic assistance software, a medical artificial intelligence solution that detects skin cancer.The clinical trial was a multi-center, retrospective study to prove the clinica
The management conflict between Hanmi Science, the Hanmi Pharmaceutical Group holding company, and Lim Jong-yoon, the eldest son of the late founder and president of Hanmi Pharmaceutical, is deepening.After Hanmi Science criticized Lim, the latter hit back."Hanmi Pharm's public relations team claims
The Korea National Enterprise for Clinical Trials (KoNECT) will co-host the "Global Investment Attraction Strategy Seminar for Korean Biotech Firms" with Harvest integrated Research Organization (HiRO) on March 28.The seminar will be held for the first time to provide networking with global investor
Celltrion is expanding its market presence in Peru, a key Latin American market, with successful public tender wins.Celltrion’s Truxima 500mg (rituximab) won the tender for the Peruvian Ministry of Health (Centro Nacional de Abastecimiento de Recursos Estratégicos en Salud, CENARES), the largest pub
Dong-A ST and IMBiologics said they have entered into a research collaboration agreement to develop a novel antibody drug candidate.The collaboration involves IMBiologics deploying its ePENDY (enhanced/engineered Pentamer body) platform technology.Unlike the conventional IgG antibody-based modalitie
Sanofi-Aventis Korea has extended the expiration date of its hemophilia A treatment Eloctate (efmoroctocog alfa) in Korea, following a controversy over mislabeling the drug's expiration date.Sanofi said Wednesday that it has received approval from the Ministry of Food and Drug Safety (MFSD) to exten
New drugs with different mechanisms of action have recently entered the ulcerative colitis (UC) treatment market in Korea, heralding fierce competition.Last Friday, the Ministry of Food and Drug Safety (MFDS) approved Lilly's interleukin-23 (IL-23) inhibitor Omvoh (mirikizumab), giving Korean patien
Korean bio ventures are increasingly withdrawing their initial public offerings (IPOs) voluntarily after the stock market regulator Korea Exchange (KRX) has taken steps to implement a more rigorous review process.Most recently, Pinotbio voluntarily withdrew its Kosdaq listing plan on Wednesday, nine
Kim Joo-ah, 3, who underwent successful heart transplant surgery, was safely discharged from Severance Hospital on Feb. 8, according to the hospital.The Lunar New Year was a special holiday for Joo-ah's family, with the entire family gathering at her home to eat tteokguk, traditional sliced rice cak
SK chemicals said that it has decided not to proceed with the sale of its pharmaceutical business unit despite having previously signed a non-binding memorandum of understanding (MOU) with Glanwood Private Equity.SK chemicals' business divisions are divided into green chemicals, which produces eco-f
A research team at the Catholic University of Korea College of Medicine has recently identified a protein called Nuclear Receptor Coactivator 6 (NCOA6) as a potential inducer of gouty arthritis in joint macrophages, the primary cells responsible for innate immunity.The team, led by Professor Kim Wan
In a bid to address the looming crisis facing Korea's stroke treatment system, Korean Stroke Society (KSS) held a press conference at the Westin Josun Seoul aimed to dissect the current state of stroke care in the country and propose strategies to strengthen the healthcare infrastructure, especially
Y-Biologics said Wednesday that it has signed a licensing-out deal with VaxCell Bio, a company specializing in anticancer immune cell therapies, for its anti-PD-L1 antibody “YBL-007” sequence.Under the agreement, VaxCell Bio has the exclusive right to use the YBL-007 sequence in the research, develo
Huons' sales exceeded 500 billion won ($375 million) last year, thanks to increased pharmaceutical exports and efficient management of sales and management expenses.In a public filing on Wednesday, the company disclosed its preliminary consolidated operating results for 2023.According to the disclos
After posting strong growth last year, Boryung aims to continue its momentum this year and join the “Trillion Won Club.” The company's confidence is fueled by increased sales across all business areas and success in the anticancer area.Boryung CEO Chang Doo-hyun (Daniel Chang) recently met with repo